About Jeffrey Wesley
Jeffrey Wesley is a director at Iaso Therapeutics.
Jeffrey Wesley first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Wesley in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Wesley works with at each company, as listed on that company's latest Form D.
Iaso Therapeutics, Inc. · Form D, Jan 14, 2026
SK
Steve Kuemmerie
Director
RF
Robert Forgey
President and CEO, director
XH
Xuefei Huang
Executive officer and director
DP
Donald Parfet
Director